
“Unlocking Potential: A Look at COYA’s Upcoming Catalysts for Growth – Seeking Alpha Analysis”
Potential Breakthrough in Amyotrophic Lateral Sclerosis Treatment Researchers are on the brink of a major advancement in the treatment of Amyotrophic Lateral Sclerosis (ALS), with the potential initiation of a phase 2b study using COYA-302 expected in 2025. This promising development is contingent upon successful clearance by the FDA of an Investigational New Drug (IND)…